You are on page 1of 14

Ototoxicity

Ototoxicity of Ototopical Antibiotics


• Systemic administration of
Aminoglycosides cause both cochlear and
vestibular toxicity
• Aminoglycosides topical drops are noted
FDA approved for use in the middle ear or
open mastoid cavity
Drugs with Ototoxicity
• Aminoglycosides
• Macrolides
• Antineoplastic agents
• Loop diuretics
• Salicylates
Gentamicin
• 2~3%
• Cupula semicircular canal
– Type I hair cell loss
• Cochlear
– Outer hair cell damage
Genetics of Ototoxicity
• Mutation of mitochondrial DNA associated
with hearing disorder
Tobromycin
• 3~4%, vestibular loss
• 6%, cochlear loss
Amikacin
• 14%, cochlear loss

• Neomycin and kanamycin with high


incidence of cochlear loss
Erythromycin
• Transient cochlear loss
• Rarely permanent loss
• Dose related
Cisplatin
• 12~25%, cochlear loss
– Cochlear hair cell loss
– Degeneration of stria vascularis
– Decrease in ganglion cells
• Dose related
Furosemide
• < 1%
• Transient loss
• Abnormal stria vascularis
Aspirin
• Only transient hearing loss and tinnitus in
doses over 2700mg/day
Vancomycin
• Rare cochlear loss
• Become ototoxic combined with
aminoglycosides
Prevention
• Iron chelator, deferoxime
• Antioxidants
• Vitamin E
Mechanisms
• Aminoglycosides, formation of iron
complex, production of free radicals
• Glutathione reduction secondary to free
radicals production

You might also like